Genomic medicine research focuses on understanding the genetic causes of many common human diseases. Researchers at TRI are investigating how genomics can potentially be used to inform diagnosis, prognosis and treatment of diseases, including cancers. 

Genomics in disease - A wide range of genomics research is underway at TRI, including the use of genomics to identify targets for osteoporosis intervention, relationships between birthweight and cardiometabolic risk, and other diseases including rheumatology and ankylosing spondylitis.

  • An overview of genomics research from UQ's Diamantina Institute, based at TRI, can be viewed here
  • The UQ Centre for Clinical Genomics, located at TRI, uses innovations in gene sequencing, genotyping and proteomic technologies to research a wide range of complex diseases, including cancer, arthritis, osteoporosis, diabetes, eczema and other chronic diseases.

Genomics diagnostic service - The QUT Australian Translational Genomics Centre (ATCG) is affiliated with TRI and based at the PA Hospital, as the first genomics diagnostic service in Queensland. The facility offers rapid and comprehensive screening for cancer mutations, identifying specific mutational profiles at diagnosis required to inform whether they are suitable for treatment with certain medications. Read more.  

Microbial biology and metagenomics - Professor Mark Morrison and his team are using DNA sequencing technologies to produce new insights into the microbiome. They aim to improve methods for monitoring and adjusting the gut microbiota to improve and maintain health, and better diagnose and treat disease. Read more

Key Researchers
Peter M Visscher
Nicole Warrington
Suyinn Chong
David Evans
Geoffrey Faulkner
Mark Morrison
Matthew Arthur Brown
Mitchell Stark
Show More ...
Click a program below to learn more
Cancer Genomics
Osteoporosis and Bone Disease
World first genetic and environmental risks identified for common form of childhood epilepsy A new study of childhood epilepsy has identified maternal smoking in pregnancy as an important risk factor...Read more
QUT and UQ researchers based at TRI are part of team looking to improve health outcomes among Aboriginal and Torres Strait Islander communities by better understanding genetic association with...Read more
Over $5.9 million in NHMRC funding awarded to TRI-based researchers for 2019 In the latest round of NHMRC funding announced this month, TRI-based researchers from UQ, QUT and Mater-UQ have secured...Read more

Identifying cancer-causing genetic mutations

Identifying cancer-causing genetic mutations

Professor Matt Brown is working to develop treatments, for cancer and immune-related diseases, based on a knowledge of genetic mutations and variants. 

Australian Translational Genomics Centre (ATGC) The Queensland University of Technology Australian Translational Genomics Centre (ATGC) was established in 2016 to meet the needs of researchers into...Read more
Professor Geoff Faulkner wins prize for Excellence in International Scientific Collaboration Professor Geoff Faulkner of Mater Research and the Queensland Brain Institute , alongside research...Read more
Queensland Mass Spectrometry Symposium The Queensland Mass Spectrometry Symposium will showcase cutting edge mass spectrometry research and facilities in Queensland, focussed workshops, poster...Read more
Is binge-eating in the Genes? Binge-eating in teenagers may be linked to a gene variation, according to new research from the University of Queensland. The UQ Diamantina Institute’s Professor...Read more

Rheumatoid arthritis vaccine

Rheumatoid Arthritis vaccine 

Professor Ranjeny Thomas has led the development and Phase I clinical trial of a first-in-class immunotherapy for the treatment of Rheumatoid Arthritis (RA).